Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials-Reference-Cited by-同舟云学术

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

Published:2012-02 Issue:9814 Volume:379 Page:432-444
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Funder

BHF Centre for Research Excellence

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. Introduction and methods,1990

3. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors vs tamoxifen;Dowsett;J Clin Oncol,2010

4. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Lancet,2011

5. ‘Classical’ CMF vs a 3-weekly intravenous CMF schedule;Engelsman;Eur J Cancer,1991

Cited by 1709 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into cardioprotection in breast cancer patients undergoing physical exercise during chemotherapy: A systematic review and meta-analysis;Current Problems in Cardiology;2024-10

2. Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives;Biomedicine & Pharmacotherapy;2024-10

3. Neoadjuvant Chemotherapy with Concurrent Letrozole for Estrogen Receptor-Positive and HER2-Negative Breast Cancer: An Open-Label, Single-Center, Nonrandomized Phase II Study (NeoCHAI);Cancers;2024-09-10

4. Abemaciclib Therapy Using the MonarchE Criteria Results in Large Numbers of Excess Axillary Node Clearances—Time to Pause and Reflect?;Cancers;2024-09-04

5. How We Monitor Cardiac Health in Breast Cancer Survivors;Journal of Clinical Oncology;2024-09-03